Skip to main content

Table 2 Mean annual costs per patient for highest and lowest cost scenarios across cohorts

From: The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis

  Non-asthma (n = 2411) Mild/Moderate asthma (n = 3975) Severe asthma (n = 808)
  Low High Low High Low High
Clinical activitya £ 350 ± 546 £ 1111 ± 2372 £ 491 ± 630 £ 1579 ± 2902 £ 911 ± 907 £ 2799 ± 3705
Prescription drugsa £ 210 ± 790 £ 212 ± 700 £ 487 ± 957 £ 493 ± 947 £ 1692 ± 2369 £ 1734 ± 2346
Total cost £ 560 £ 1324 £ 978 £ 2072 £ 2603 £ 4533
  1. Six scenarios were created for clinical costs to capture uncertainty around the likely consultation to be costed (2 scenarios) and median, and IQ ranges (3 scenarios)
  2. aMean ± SD